Synopsis : Ananya Birla-backed Svatantra Microfin has filed DRHP for a Rs 3,000 crore IPO comprising a Rs 1,500 crore fresh issue and Rs 1,500 crore OFS. The second-largest NBFC-MFI in India reported a 46% rise in FY26 profit to Rs 649 crore, but asset quality and microfinance-sector risks remain key concerns.
Ananya Birla-promoted microfinance non-banking financial company (NBFC) Svatantra Microfin has filed its draft red herring prospectus (DRHP) with the Securities and Exchange Board of India (SEBI) for a proposed Rs 3,000 crore initial public offering.
The proposed IPO comes at a time when India’s financial services sector continues to see strong investor interest, particularly in companies focused on lending and financial inclusion.
According to the DRHP, the issue will consist of both a fresh issue and an offer for sale, giving investors an opportunity to participate in one of India’s major microfinance listings.
Svatantra Microfin IPO: What is the issue size?
Svatantra Microfin’s proposed IPO will be a Rs 3,000 crore book-built issue.
The offer will comprise:
- Fresh issue: Rs 1,500 crore
- Offer for Sale: Rs 1,500 crore
- Face value: Rs 10 per equity share
The company will receive funds only from the fresh issue component.
The Rs 1,500 crore OFS will allow existing shareholders to sell part of their holdings, but Svatantra Microfin itself will not receive any proceeds from that portion.
Where will Svatantra Microfin use the IPO money?
The majority of the funds raised through the fresh issue will be used to strengthen the company’s Tier-1 capital base.
This is particularly important for a lending company because a stronger capital position can support future business expansion and allow the company to meet its capital requirements as its loan book grows.
Svatantra plans to use the capital primarily for onward lending, while a smaller portion will be used to meet expenses related to the IPO.
The company may also consider a pre-IPO placement of up to Rs 300 crore before filing its final offer document.
If the pre-IPO placement goes ahead, the amount raised through it will be deducted from the fresh issue component of the IPO.
Who are the bankers and registrar?
Svatantra Microfin has appointed several major investment banks to manage the proposed IPO.
The lead managers are:
Axis Capital, Avendus Capital Private, IIFL Capital Services, Kotak Mahindra Capital Company and SBI Capital Markets.
MUFG Intime India has been appointed as the registrar to the issue.
Svatantra Microfin FY26 results: Profit jumps 46%
Svatantra Microfin reported strong financial growth during FY26.
The company’s profit after tax increased nearly 46% year-on-year to Rs 649 crore, compared with Rs 445 crore in FY25.
Revenue from operations also increased around 20% year-on-year to Rs 4,120 crore, compared with Rs 3,441 crore in the previous financial year.
The combination of double-digit revenue growth and faster profit expansion highlights the company’s recent improvement in profitability.
However, investors will need to assess whether this growth can continue as the company expands its lending operations.
What does Svatantra Microfin do?
Svatantra Microfin is an inclusion-focused NBFC whose primary business is providing microfinance loans.
The company caters primarily to underserved segments of the population and operates across multiple parts of India.
According to its DRHP, Svatantra Microfin claims to be the second-largest NBFC-MFI in India.
As of March 31, 2026, the company had a pan-India network of 2,253 branches.
Its large branch network gives it access to a wide customer base and provides a platform for expanding its lending operations.
What are the key risks?
Despite its strong growth, the proposed IPO comes with several risks linked to the microfinance industry.
Microfinance lenders are particularly sensitive to changes in borrower repayment behaviour and collection efficiency.
An increase in loan write-offs or a decline in collections could put pressure on profitability.
The company also faces the risk of rising non-performing assets (NPAs) if borrowers struggle to repay their loans.
Changes in interest rates could also affect borrowing costs and lending margins.
Another concern is the availability of capital. Any disruption in the company’s key sources of funding could restrict its ability to grow its loan book.
The broader microfinance industry can also be affected by economic downturns, regulatory changes and regional disruptions.
What investors should watch before the IPO
The DRHP filing is only the first major step in Svatantra Microfin’s IPO process. Investors will need to wait for further details, including the final price band, valuation and IPO dates.
The most important factor will be whether the company’s growth and profitability justify the valuation eventually assigned to it.
Its strong FY26 performance, large branch network and position among India’s largest microfinance NBFCs could support investor interest.
At the same time, asset quality, collection efficiency, capital requirements and the overall health of India’s microfinance sector will remain critical factors to monitor.
Bottom line
Svatantra Microfin’s proposed Rs 3,000 crore IPO is set to bring another major financial-services company to India’s primary market.
The company plans to raise Rs 1,500 crore through a fresh issue, with most of the proceeds earmarked for strengthening its Tier-1 capital and supporting future lending.
With FY26 profit rising 46% to Rs 649 crore and revenue increasing 20% to Rs 4,120 crore, the company enters the IPO process with strong recent financial growth.
But the real test for investors will be the valuation.
The final price band and resulting valuation will determine whether the company’s growth profile offers enough upside to compensate investors for the risks associated with the microfinance business.
Disclaimer
This article is for informational and educational purposes only and does not constitute financial advice, an offer, solicitation or recommendation to buy or subscribe to any IPO or security. The IPO details are based on the company’s DRHP and may change during the regulatory and offer process. Investors should read the final offer documents carefully and conduct their own due diligence before making any investment decision.
.jpg)